Yale Launches Comprehensive DNA Sequencing Project, With Aim of Predicting, Preventing, and Treating Gene-related Diseases
Generations, a collaboration between Yale School of Medicine and Yale New Haven Health System, is one of the largest DNA sequencing projects of its kind in the United States.
Yale-developed Scorecard Promotes Better Clinical Trial Data Sharing
A tool developed by researchers at Yale, Stanford, and Bioethics International can promote greater sharing of clinical trial data by pharmaceutical companies. While nearly one-third of the companies that the researchers assessed met standards for sharing data, others could be more transparent to the benefit of science and the public, the researchers said.
Preprint Server for Health Sciences Will ‘Accelerate’ Research
Yale University, Cold Spring Harbor Laboratory (CSHL), and publisher BMJ have announced the forthcoming launch of medRxiv [pronounced “med-archive”], a free online archive and distribution service for preprints in the medical and health sciences.
Yale Study Finds Link Between Medicaid Expansion and Equity in Cancer Care
Racial disparities in timely cancer treatment disappeared in states that expanded Medicaid under the Affordable Care Act (ACA), according to an analysis of over 30,000 health records led by researchers at Yale Cancer Center. The findings were presented at the American Society of Clinical Oncology (ASCO) 2019 annual meeting.
Low mobility predicts hospital readmission in older heart attack patients
Close to 20% of elderly adults who have suffered a heart attack will be readmitted to the hospital within 30 days. Performance on a simple mobility test is the best predictor of whether an elderly heart attack patient will be readmitted, a Yale-led study reports.
Antiretroviral Therapy Crucial in Preventing non-Hodgkin Lymphoma, YSPH Study Reinforces
A research team led by the Yale School of Public Health has found that for people living with HIV/AIDS, both recent immunosuppression and prolonged HIV viremia play important and independent roles in the development of non-Hodgkin lymphoma.
Since 1990s, Heart Attacks Have Become Less Deadly and Frequent for Americans
Heart attack prevention and outcomes have dramatically improved for American adults in the past two decades, according to a Yale study in JAMA Network Open. Compared to the mid-1990s, Americans today are less likely to have heart attacks and also less likely to die from them, said the researchers.
Nearly half of adults with heart disease can’t afford their medical bills
More than 45% of non-elderly adults with atherosclerotic cardiovascular disease (ASCVD) report financial hardship due to the associated medical bills, according to a Yale research team. Worse still, about one in five report being unable to pay those medical bills at all, said the researchers.
Yale study evaluates use of cognitive-behavioral therapy to treat opioid use disorder and chronic pain
A study by Yale researchers led by Declan Barry, PhD, Associate Professor of Psychiatry and Child Study, developed an integrated treatment approach combining psychotherapy with medication-assisted treatment.
Why Hospitals Should Let You Sleep
If part of a hospital stay is to recover from a procedure or illness, why is it so hard to get any rest? There is more noise and light than is conducive for sleep. And nurses and others visit frequently to give medications, take vitals, draw blood or perform tests and checkups — in many cases waking patients to do so.Source: The New York Times
Krumholz, Spatz receive funding to develop new 24/7 blood pressure monitor
The National Institute of Biomedical Imaging and Bioengineering has awarded a $1.2 million, four-year grant to investigators at Texas A&M University and Yale University for the development of a wrist-worn, cuffless blood pressure monitoring system.
CERSI Obtains FDA Grant Renewal
Joseph S. Ross, MD, MHS, associate professor of medicine (general medicine) and public health (health policy and management) was awarded a U.S. Food & Drug Administration (FDA) grant renewal up to $20M for work on the Yale-Mayo Clinic FDA Center of Excellence in Regulatory Science and Innovation (CERSI). The grant was recently renewed for years three through seven.
Rosenheck, Rhee Analyze Prescription Rates Without a Psychiatric Diagnosis
A new study by Robert Rosenheck, MD, Professor of Psychiatry and of Health Policy, and Greg Rhee, PhD, MSW, Postdoctoral Fellow at Yale School of Medicine, estimates the national rates of psychotropic medication prescriptions for patients who do not receive a psychiatric diagnosis.
Yale center dedicated to research on older adults receives renewed funding
For the fifth consecutive time, the Yale Claude D. Pepper Older Americans Independence Center (OAIC) has been renewed for funding from the National Institute on Aging (NIA). The Center is one of only two such programs nationwide to receive continuous NIA support since it was first funded in 1992, marking more than 25 years of excellence in geriatrics and aging research under the leadership of Geriatrics Section Chief Dr. Mary Tinetti, Dr. Thomas Gill, and Dr. Terri Fried.
Improving the World’s Largest Health System—Scholars Convene at YSPH to Plan for Future
Some 200 researchers and health leaders gathered at Yale University for the second biennial conference of the China Health Policy and Management Society (CHPAMS), focusing on the Healthy China 2030 national blueprint for the health of the 1.3 billion Chinese.
New cancer immunotherapy drugs rapidly reach patients after approval
The majority of patients eligible for cancer immunotherapy drugs known as checkpoint inhibitors received treatment within a few months of FDA approval, according to a new Yale-led study. The finding suggests that cancer immunotherapies are adopted at a much quicker pace than is typical for newly approved medical treatments, the researchers said. However, patients receiving the therapies are older than those in the clinical trials used to evaluate them, pointing to a disconnect between research and practice that should be addressed, they noted.
Experts Convene to Discuss Improving Reproducible Research Practices for Schools of Public Health
It is estimated that more than $200 billion is spent on biomedical research every year. The return on that investment is too low, agree a group of experts who gathered at the Yale School of Public Health to discuss reproducibility and transparency in research last week.